CYTK
CYTOKINETICS INC
CYTOKINETICS INC (CYTK) has 25 SEC Form 4 filings (49 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is EVP Research & Development Malik Fady Ibraham with 3 filings. Insiders have net sold $8.6M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Robert I. Blum
- Employees:498
- HQ:South San Francisco, CA, US
- IPO:2004-04-30
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$12.1M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$10.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| President & CEO | Sale | 7,500 | $615K | Jul 14 | SEC ↗ | |
| EVP Research & Development | Sale | 3,500 | $303K | Jul 7 | SEC ↗ | |
| EVP, Chief Commercial Officer | Sale | 15,000 | $1.3M | Jul 2 | SEC ↗ | |
| EVP, Chief Financial Officer | Sale | 1,112 | $98K | Jul 2 | SEC ↗ | |
Blum Robert IFirst filing | President & CEO | Sale | 7,500 | $637K | Jul 2 | SEC ↗ |
| EVP, Chief Financial Officer | Sale | 38,730 | $3.2M | Jun 29 | SEC ↗ | |
Lee SungFirst filing | EVP, Chief Financial Officer | Sale | 3,134 | $266K | Jun 29 | SEC ↗ |
| EVP Research & Development | Sale | 3,500 | $278K | Jun 23 | SEC ↗ | |
Malik Fady IbrahamFirst filing | EVP Research & Development | Sale | 3,500 | $238K | Jun 9 | SEC ↗ |
Kaye Edward M. MDFirst in 6 months | Director | Sale | 2,933 | $223K | Jun 1 | SEC ↗ |
Callos AndrewFirst in 6 months | EVP, Chief Commercial Officer | Sale | 15,000 | $1.1M | Jun 1 | SEC ↗ |
PARSHALL B LYNNEFirst filing | Director | Sale | 5,000 | $370K | Jun 1 | SEC ↗ |
Callos AndrewFirst filing | EVP, Chief Commercial Officer | Sale | 52,486 | $3.5M | Dec 5 | SEC ↗ |
Congress trading CYTK
See timeline →- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-06-30
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
CYTOKINETICS INC is in the Healthcare sector.